Vitiligo: pathogenesis, clinical variants and treatment approaches
Vitiligo is a common chronic acquired disease of pigmentation whose etiology is unknown,
which usually occurs with asymptomatic whitish patch or macule. Although several …
which usually occurs with asymptomatic whitish patch or macule. Although several …
Autoimmunity in vitiligo: Therapeutic implications and opportunities
BK Khaitan, T Sindhuja - Autoimmunity Reviews, 2022 - Elsevier
Vitiligo is an acquired chronic pigmentary disorder affecting the melanocytes, mainly in the
skin and mucosae. It occurs due to the dynamic interaction between genetic and …
skin and mucosae. It occurs due to the dynamic interaction between genetic and …
Vitiligo: focus on clinical aspects, immunopathogenesis, and therapy
Vitiligo is an acquired chronic depigmenting disorder of the skin, with an estimated
prevalence of 0.5% of the general population, characterized by the development of white …
prevalence of 0.5% of the general population, characterized by the development of white …
Vitiligo: a review
C Bergqvist, K Ezzedine - Dermatology, 2020 - karger.com
Vitiligo, a common depigmenting skin disorder, has an estimated prevalence of 0.5–2% of
the population worldwide. The disease is characterized by the selective loss of melanocytes …
the population worldwide. The disease is characterized by the selective loss of melanocytes …
Concise review of recent studies in vitiligo
M Allam, H Riad - Qatar medical journal, 2014 - qscience.com
Vitiligo is an acquired pigmentry disorder of the skin and mucous membranes which
manifests as white macules and patches due to selective loss of melanocytes. Etiological …
manifests as white macules and patches due to selective loss of melanocytes. Etiological …
Vitiligo: an update on pathophysiology and treatment options
R Speeckaert, N van Geel - American journal of clinical dermatology, 2017 - Springer
The pathophysiology of vitiligo is becoming increasingly clarified. In non-segmental vitiligo,
early factors include activation of innate immunity, inflammasome activation, oxidative stress …
early factors include activation of innate immunity, inflammasome activation, oxidative stress …
Vitiligo as a systemic disease
T Lotti, AM D'Erme - Clinics in dermatology, 2014 - Elsevier
Vitiligo is an acquired depigmentary skin disorder of unknown etiology. Vitiligo is not only a
disease of melanocytes of the skin. Human melanocytes are derived from the neural crest …
disease of melanocytes of the skin. Human melanocytes are derived from the neural crest …
Modern vitiligo genetics sheds new light on an ancient disease
RA Spritz - The Journal of dermatology, 2013 - Wiley Online Library
Vitiligo is a complex disorder in which autoimmune destruction of melanocytes results in
white patches of skin and overlying hair. Over the past several years, extensive genetic …
white patches of skin and overlying hair. Over the past several years, extensive genetic …
[PDF][PDF] Vitiligo update
RM Halder, JL Chappell - Seminars in cutaneous medicine and …, 2009 - cdn.mdedge.com
Vitiligo is an acquired dyschromia of the skin in which there is a loss of epidermal
melanocytes. The prevalence of vitiligo is approximately 1% in the United States and 0.1-2 …
melanocytes. The prevalence of vitiligo is approximately 1% in the United States and 0.1-2 …
Vitiligo: a comprehensive overview: part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work …
A Alikhan, LM Felsten, M Daly… - Journal of the American …, 2011 - Elsevier
Vitiligo is an acquired pigmentary disorder of unknown etiology that is clinically
characterized by the development of white macules related to the selective loss of …
characterized by the development of white macules related to the selective loss of …